APA (7th ed.) Citation

Starling, A. J., Kudrow, D., Kapur, N., Awad, S. F., Grossman, S. W., Patel, F., . . . Lipton, R. B. (2026). Long-Term Reductions in Headache Frequency, Severity, and Disability with Eptinezumab in Adults with Chronic Migraine: Results from the PREVAIL Trial. Pain & Therapy, 15(3), 785. https://doi.org/10.1007/s40122-026-00831-0

Chicago Style (17th ed.) Citation

Starling, Amaal J., David Kudrow, Neha Kapur, Susanne F. Awad, S. Wald Grossman, Foram Patel, Jessica Ailani, Andrew Blumenfeld, and Richard B. Lipton. "Long-Term Reductions in Headache Frequency, Severity, and Disability with Eptinezumab in Adults with Chronic Migraine: Results from the PREVAIL Trial." Pain & Therapy 15, no. 3 (2026): 785. https://doi.org/10.1007/s40122-026-00831-0.

MLA (9th ed.) Citation

Starling, Amaal J., et al. "Long-Term Reductions in Headache Frequency, Severity, and Disability with Eptinezumab in Adults with Chronic Migraine: Results from the PREVAIL Trial." Pain & Therapy, vol. 15, no. 3, 2026, p. 785, https://doi.org/10.1007/s40122-026-00831-0.